Abstract
The ability to accurately model human cancer in mice enables in vivo examination of the biological mechanisms related to cancer initiation and progression as well as preclinical testing of new anticancer treatments and potential targets. The emergence of the genetically engineered Sleeping Beauty system of insertional mutagenesis has led to the development of a new generation of genetic mouse models of cancer and identification of novel cancer-causing genes. This chapter reviews the published cancer models of Sleeping Beauty and strategies using available strains to generate several models of cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Collier LS, Carlson CM, Ravimohan S et al (2005) Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436:272–276
Howell VM (2012) Sleeping beauty – a mouse model for all cancers? Cancer Lett 317:1–8
Ivics Z, Hackett PB, Plasterk RH et al (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91:501–510
Geurts AM, Collier LS, Geurts JL et al (2006) Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet 2:e156
Collier LS, Adams DJ, Hackett CS et al (2009) Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res 69:8429–8437
Dupuy AJ, Akagi K, Largaespada DA et al (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436:221–226
Dupuy AJ, Rogers LM, Kim J et al (2009) A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 69:8150–8156
Van Der Weyden L, Arends MJ, Rust AG et al (2012) Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1. Mol Cancer 11:29
Van Der Weyden L, Papaspyropoulos A, Poulogiannis G et al (2012) Loss of RASSF1A synergizes with deregulated RUNX2 signaling in tumorigenesis. Cancer Res 72:3817–3827
Perez-Mancera PA, Rust AG, Van Der Weyden L et al (2012) The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486:266–270
O'donnell KA, Keng VW, York B et al (2012) A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci U S A 109:E1377–E1386
Berquam-Vrieze KE, Nannapaneni K, Brett BT et al (2011) Cell of origin strongly influences genetic selection in a mouse model of T-ALL. Blood 118:4646–4656
Tang JZ, Carmichael CL, Shi W et al (2013) Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia. Proc Natl Acad Sci U S A 110:6091–6096
Zanesi N, Balatti V, Riordan J et al (2013) A Sleeping Beauty screen reveals NF-kB activation in CLL mouse model. Blood 121:4355–4358
Keng VW, Villanueva A, Chiang DY et al (2009) A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. Nat Biotechnol 27:264–274
March HN, Rust AG, Wright NA et al (2011) Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis. Nat Genet 43:1202–1209
Starr TK, Scott PM, Marsh BM et al (2011) A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis. Proc Natl Acad Sci U S A 108:5765–5770
Starr TK, Allaei R, Silverstein KA et al (2009) A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science 323:1747–1750
Mann KM, Ward JM, Yew CC et al (2012) Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad Sci U S A 109:5934–5941
Rahrmann EP, Watson AL, Keng VW et al (2013) Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet 45:756–766
Larson JD, Largaespada DA (2012) Review: in vivo models for defining molecular subtypes of the primitive neuroectodermal tumor genome: current challenges and solutions. In Vivo (Athens, Greece) 26:487–500
Wu X, Northcott PA, Dubuc A et al (2012) Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482:529–533
Karreth FA, Tay Y, Perna D et al (2011) In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147:382–395
Quintana RM, Dupuy AJ, Bravo A et al (2013) A transposon-based analysis of gene mutations related to skin cancer development. J Invest Dermatol 133:239–248
Dupage M, Dooley AL, Jacks T (2009) Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4:1064–1072
Brett BT, Berquam-Vrieze KE, Nannapaneni K et al (2011) Novel molecular and computational methods improve the accuracy of insertion site analysis in Sleeping Beauty-induced tumors. PLoS One 6:e24668
Rawlins EL, Perl AK (2012) The a"MAZE"ing world of lung-specific transgenic mice. Am J Respir Cell Mol Biol 46:269–282
Jackson EL, Willis N, Mercer K et al (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15:3243–3248
Fasbender A, Lee JH, Walters RW et al (1998) Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest 102:184–193
Luo J, Deng ZL, Luo X et al (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2:1236–1247
Bender AM, Collier LS, Rodriguez FJ et al (2010) Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer Res 70:3557–3565
Largaespada DA, Collier LS (2008) Transposon-mediated mutagenesis in somatic cells: identification of transposon-genomic DNA junctions. Methods Mol Biol 435:95–108
Acknowledgements
V.M.H. is a Cancer Institute NSW South Wales (CINSW) Northern Translational Cancer Research Unit Fellow; E.K.C. is a CINSW Fellow. This work is supported by Cancer Council NSW and Cure Cancer Australia Foundation. Dr J. Grim and A. Knecht from the Fred Hutchinson Cancer Research Center are acknowledged for primer sequences for genotyping Rosa26SB11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Howell, V.M., Colvin, E.K. (2014). Genetically Engineered Insertional Mutagenesis in Mice to Model Cancer: Sleeping Beauty. In: Singh, S., Coppola, V. (eds) Mouse Genetics. Methods in Molecular Biology, vol 1194. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1215-5_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1215-5_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1214-8
Online ISBN: 978-1-4939-1215-5
eBook Packages: Springer Protocols